225 related articles for article (PubMed ID: 25496723)
1. Understanding HIV infection for the design of a therapeutic vaccine. Part I: Epidemiology and pathogenesis of HIV infection.
de Goede AL; Vulto AG; Osterhaus AD; Gruters RA
Ann Pharm Fr; 2015 Mar; 73(2):87-99. PubMed ID: 25496723
[TBL] [Abstract][Full Text] [Related]
2. Understanding HIV infection for the design of a therapeutic vaccine. Part II: Vaccination strategies for HIV.
de Goede AL; Vulto AG; Osterhaus AD; Gruters RA
Ann Pharm Fr; 2015 May; 73(3):169-79. PubMed ID: 25528627
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
[TBL] [Abstract][Full Text] [Related]
4. A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.
García F; Climent N; Guardo AC; Gil C; León A; Autran B; Lifson JD; Martínez-Picado J; Dalmau J; Clotet B; Gatell JM; Plana M; Gallart T;
Sci Transl Med; 2013 Jan; 5(166):166ra2. PubMed ID: 23283367
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic vaccines against HIV infection.
García F; León A; Gatell JM; Plana M; Gallart T
Hum Vaccin Immunother; 2012 May; 8(5):569-81. PubMed ID: 22634436
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy and therapeutic vaccines in HIV infection.
García F; Ruiz L; López-Bernaldo de Quirós JC; Moreno S; Domingo P
Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():84-104. PubMed ID: 16373008
[TBL] [Abstract][Full Text] [Related]
7. A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy.
Tung FY; Tung JK; Pallikkuth S; Pahwa S; Fischl MA
Vaccine; 2016 Apr; 34(19):2225-32. PubMed ID: 27002500
[TBL] [Abstract][Full Text] [Related]
8. Targeted Immune Interventions for an HIV-1 Cure.
Perreau M; Banga R; Pantaleo G
Trends Mol Med; 2017 Oct; 23(10):945-961. PubMed ID: 28890135
[TBL] [Abstract][Full Text] [Related]
9. Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial.
Gudmundsdotter L; Wahren B; Haller BK; Boberg A; Edbäck U; Bernasconi D; Buttò S; Gaines H; Imami N; Gotch F; Lori F; Lisziewicz J; Sandström E; Hejdeman B
Vaccine; 2011 Jul; 29(33):5558-66. PubMed ID: 21300092
[TBL] [Abstract][Full Text] [Related]
10. Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.
Gorse GJ; Simionescu RE; Patel GB
Clin Vaccine Immunol; 2006 Jan; 13(1):26-32. PubMed ID: 16425996
[TBL] [Abstract][Full Text] [Related]
11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
12. Vaccine and immunotherapeutic interventions.
Pantaleo G; Lévy Y
Curr Opin HIV AIDS; 2013 May; 8(3):236-42. PubMed ID: 23478912
[TBL] [Abstract][Full Text] [Related]
13. Prospects for HIV-1 therapeutic immunisation and vaccination: the potential contribution of peptide immunogens.
Sommerfelt MA; Sørensen B
Expert Opin Biol Ther; 2008 Jun; 8(6):745-57. PubMed ID: 18476786
[TBL] [Abstract][Full Text] [Related]
14. Immune interventions in HIV infection.
Carcelain G; Autran B
Immunol Rev; 2013 Jul; 254(1):355-71. PubMed ID: 23772631
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic vaccination for future management of HIV/AIDS.
Lisziewicz J; Bakare N; Lori F
Vaccine; 2003 Jan; 21(7-8):620-3. PubMed ID: 12531329
[TBL] [Abstract][Full Text] [Related]
16. HIV infection and AIDS.
Shearer WT
Prim Care; 1998 Dec; 25(4):759-74. PubMed ID: 9735117
[TBL] [Abstract][Full Text] [Related]
17. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic vaccination against HIV: current progress and future possibilities.
Puls RL; Emery S
Clin Sci (Lond); 2006 Jan; 110(1):59-71. PubMed ID: 16336205
[TBL] [Abstract][Full Text] [Related]
19. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
20. [Immunopathogenesis and therapeutic immunization in HIV-infection].
Kran AM; Kvale D
Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3112-6. PubMed ID: 17160117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
